INSIGHTS ON CLINICAL TRIAL DESIGN
-
Advancing Immunotherapy In Head And Neck Cancer: The IT-MATTERS Study
This randomized controlled pivotal Phase 3 study evaluated efficacy and safety of neoadjuvant complex biologic administered for three consecutive weeks pre-surgery.
-
Why Tax Reporting Matters In Clinical Trial Participant Payments
Clinical trial participant payments can trigger often overlooked tax reporting obligations. Learn why early visibility into payments matters and how better tracking helps avoid compliance surprises.
-
Community Connections: Leveraging Localized Patient Access In Clinical Trials
This roundtable brought together several experts to discuss how expanding community-based research can transform clinical trial recruitment and representation.
-
Cell And Gene Therapy Field Quiet In Q2
While there weren't any new gene or cell therapy approvals in Q2 2024, the U.S. approved two RNA therapies: Rytelo, an oligonucleotide telomerase inhibitor, and mRESVIA, an mRNA vaccine.
-
Gene, Cell, And RNA Therapy Landscape Continues To Thrive3/21/2025
The horizons of molecular medicine continued to expand in the Q4 2024, with pre-registration gene therapy programs up 83% from the third quarter.
-
Your Benefits To Working With A Clinical Research Marketing Agency4/28/2025
Distinguish your clinical trial through partnering with a clinical research marketing agency to effectively attract and retain eligible participant with customized campaigns and digital marketing.
-
What Everest Group's RTSM Recognition Means For The Industry12/5/2025
RTSM is transforming from a basic operational tool into a strategic driver of trial efficiency. Learn why industry recognition signals a new era of innovation and competitive advantage.
-
Delivering A Registrational GI Trial Through Ongoing Protocol Shifts10/17/2025
A biotech developing bispecific antibodies partnered with a flexible CRO to launch its first U.S. GI oncology trial, requiring strategic insight and full-service clinical support.
-
Why Early Phase Speed Depends On Oncology Expertise5/1/2026
Early phase oncology speed depends on confident, oncology‑specific decisions made upfront. Learn why scientific expertise, realistic planning, and foresight determine whether programs maintain momentum.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Explore how integrated regulatory, statistical, and operational expertise can be applied to help sponsors navigate complex development pathways and accelerate global approvals.
-
Citeline Connect is an end-to-end trial education, enrollment and recruiting platform that accelerates study startup, drives engagement, and enables community and communication surrounding clinical trials.
-
Veristat ensures that your clinical trial or program design supports your regulatory strategy, whether you plan to run a single pivotal trial or multiple trials.
-
The success of your clinical trial hinges on the patients you recruit. When you can’t find and enroll the right patients at the right time, you may experience go-to-market delays and financial losses. With AutoCruitment, you can secure the patients you need, complete your trial on time, and improve your study outcomes.
-
Discover how Scout supports patient retention with people-first solutions for reimbursement and travel at no cost to sites.